A hybrid microrobotic platform combining living bacteria, nanoparticles and targeted chemotherapy has achieved 82.4 percent ...
From self-driving laboratories to advanced cellular models, ELRIG Drug Discovery 2026 showcases technologies helping researchers generate better data, evaluate drug candidates and improve early ...
Researchers at Nagoya University have identified BCAT1, an enzyme involved in proline supply for collagen synthesis, as a ...
Cambridge biotech bit.bio has released ioAstrocytes 2.0, a genetically matched human astrocyte model designed to support ...
PacBio and AI drug discovery company TychoBio are generating full-length RNA datasets from more than 10,000 samples to train ...
Poor recovery, inconsistent growth and changes in morphology can affect organoid research. How much experimental variability ...
TechBio firm WhiteLab Genomics has closed a $26 million Series B round to expand in vivo validation of its AI-designed ...
Researchers at the University of Birmingham have identified the P2X7 receptor as a key driver of neuroinflammation in human ...
Three leading scientists in protein science, structural biology and AI will headline the Protein Sciences in Drug Discovery ...
Stability problems can derail promising biologics late in development. Bringing high-throughput testing earlier into ...
Scientists at Scripps Research have engineered a synthetic protein capable of binding to Toll-like receptor 4 within the cell ...
Researchers at Albert Einstein College of Medicine have identified a cellular recycling pathway whose age-related decline allows senescent 'zombie' cells to evade immune clearance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results